Inclusion Criteria:  History of recurrent symptomatic paroxysmal AF (PAF) with ≥1 episode reported and documented within the 365 days prior to enrollment; PAF is defined as AF episodes that last ≥30 seconds in duration and terminate within 7 days. Patients with an indication to an ablation procedure with 3D high-density mapping system according to current international and local guidelines (and future revisions), existing IFU and per physician discretion Patients who are willing and capable of providing informed consent, participating in all testing at an approved clinical investigational center. Patients whose age is 18 years or above, and of legal age to give informed consent specific to state and national law.  Exclusion Criteria:  Patients who have persistent or long-standing persistent AF (>1 AF episodes lasting greater than 7 days, with no episodes having lasted greater than 30 days, within the past year) Patients who are currently enrolled in another investigational study or registry that would directly interfere with the current study, except when the subject is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments Patients who are unwilling or unable to sign an authorization to use and disclose health information or an Informed Consent. Patients unavailable or not willing to complete follow up visits and examination for the duration of the study at the center. Life expectancy ≤ 12 months per physician judgment. Patients who have undergone a previous cardiac ablation within 90 days prior to enrollment; Unrecovered/unresolved Adverse Events from any previous invasive procedure; Women of childbearing potential who are, or plan to become, pregnant during the time of the study (method of assessment upon physician's discretion) Left atrial size > 60 mm diameter on echocardiogram Left atrial thrombus in pre-procedure imaging within 4 weeks of the ablation procedure. AF secondary to electrolyte imbalance, thyroid disease or reversible non- cardiac cause. History of prior surgical ablation for AF or atypical atrial flutter, including MAZE or mini MAZE